By Dr Angela Sheu

Journal articles

Sheu A; Blank RD; Tran T; Bliuc D; Greenfield JR; White CP; Center JR, 2023, 'Associations of Type 2 Diabetes, Body Composition, and Insulin Resistance with Bone Parameters: The Dubbo Osteoporosis Epidemiology Study', JBMR Plus, 7, http://dx.doi.org/10.1002/jbm4.10780

Sheu A; O’Connell RL; Jenkins AJ; Tran T; Drury PL; Sullivan DR; Li LP; Colman P; O’Brien R; Kesäniemi YA; Center JR; White CP; Keech AC, 2023, 'Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Diabetes/Metabolism Research and Reviews, 39, http://dx.doi.org/10.1002/dmrr.3631

Sheu A; Greenfield JR; White CP; Center JR, 2023, 'Contributors to impaired bone health in type 2 diabetes', Trends in Endocrinology and Metabolism, 34, pp. 34 - 48, http://dx.doi.org/10.1016/j.tem.2022.11.003

Sheu A; Bliuc D; Tran T; White CP; Center JR, 2022, 'Fractures in type 2 diabetes confer excess mortality: The Dubbo osteoporosis epidemiology study', Bone, 159, http://dx.doi.org/10.1016/j.bone.2022.116373

Sheu A; Greenfield JR; White CP; Center JR, 2022, 'Assessment and treatment of osteoporosis and fractures in type 2 diabetes', Trends in Endocrinology and Metabolism, 33, pp. 333 - 344, http://dx.doi.org/10.1016/j.tem.2022.02.006

Sheu A; Chan Y; Ferguson A; Bakhtyari MB; Hawke W; White C; Chan YF; Bertolino PJ; Woon HG; Palendira U; Sierro F; Lau SM, 2018, 'A proinflammatory CD4⁺ T cell phenotype in gestational diabetes mellitus', Diabetologia, 61, pp. 1633 - 1643, http://dx.doi.org/10.1007/s00125-018-4615-1

Sheu A; Lopes LBA; Eisman J; Center JR, 2017, 'Osteoporosis management in 2017: still thin and fragmented', Internal Medicine Journal, 47, pp. 1329 - 1330, http://dx.doi.org/10.1111/imj.13598

Munoz MA; Jurczyluk J; Mehr S; Chai RC; Arts RJW; Sheu A; McMahon C; Center JR; Singh-Grewal D; Chaitow J; Campbell DE; Quinn JMW; Alexandrov K; Tnimov Z; Tangye SG; Simon A; Phan TG; Rogers MJ, 2017, 'Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency', Journal of Allergy and Clinical Immunology, 140, pp. 873 - 875.e6, http://dx.doi.org/10.1016/j.jaci.2017.02.033

Sheu A; Center J, 2017, 'Osteoporosis in postmenopausal women: Key aspects of prevention and treatment', Medicine Today, 18, pp. 29 - 38

Sheu A; Depczynski B; O'Sullivan AJ; Luxton G; Mangos G, 2016, 'The effect of different glycaemic states on renal transplant outcomes', Journal of Diabetes Research, http://dx.doi.org/10.1155/2016/8735782

Sheu A; Diamond T, 2016, 'Secondary osteoporosis', Australian Prescriber, 39, pp. 85 - 87, http://dx.doi.org/10.18773/austprescr.2016.038

Sheu A; Diamond T, 2016, 'Bone mineral density: Testing for osteoporosis', Australian Prescriber, 39, pp. 35 - 39, http://dx.doi.org/10.18773/austprescr.2016.020

Vandenberg JI; Mann SA; Castro ML; Ohanian M; Guo G; Zodgekar PR; Sheu A; Stockhammer K; Fatkin D; Subbiah RN, 2012, 'R222Q SCN5A Mutation Is Associated With Reversible Ventricular Ectopy and Dilated Cardiomyopathy', Journal of the American College of Cardiology, 60, pp. 1566 - 1573, http://dx.doi.org/10.1016/j.jacc.2012.05.050

Fatkin D; Yeoh TB; Hayward CS; Benson V; Sheu A; Richmond Z; Feneley MP; Keogh AM; Macdonald PS, 2011, 'A Randomised, Placebo-controlled Trial of Carvedilol in Early Familial Dilated Cardiomyopathy', Heart Lung and Circulation, 20, pp. 566 - 573

Fatkin D; Yeoh TB; Hayward CS; Benson V; Sheu A; Richmond Z; Feneley MP; Keogh AM; Macdonald PS, 2011, 'Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy', Circulation: Cardiovascular Genetics, 4, pp. 342 - 348

Back to profile page